Arbyn, Marc

Metaprop: a Stata command to perform meta-analysis of binomial data

Nyaga, V. N., Arbyn, M., & Aerts, M. (2014) · Archives of Public Health

Meta-analysis and systematic reviewsStatistical Methods in Epidemiology

Cited by 2,139

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 1,810

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative

Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., Arbyn, M., Basu, P., Bray, F., & Vaccarella, S. (2023) · The Lancet Global Health

Cervical Cancer and HPV ResearchGlobal Cancer Incidence and Screening

Cited by 1,616

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses

Arbyn, M., Smith, S. B., Temin, S., Sultana, F., & Castle, P. (2018) · BMJ

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 851

Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis

Kyrgiou, M., Athanasiou, A., Paraskevaidi, M., Mitra, A., Kalliala, I., Martin-Hirsch, P., Arbyn, M., Bennett, P., & Paraskevaidis, E. (2016) · BMJ

Preterm Birth and ChorioamnionitisCervical Cancer and HPV Research

Cited by 495

Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women

Clarke, M. A., Long, B. J., Del Mar Morillo, A., Arbyn, M., Bakkum-Gamez, J. N., & Wentzensen, N. (2018) · JAMA Internal Medicine

Endometrial and Cervical Cancer TreatmentsCancer Risks and Factors

Cited by 426

2020 list of human papillomavirus assays suitable for primary cervical cancer screening

Arbyn, M., Simon, M., Peeters, E., Xu, L., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Bonde, J., Ostrbenk Vanlencak, A., Zhao, F.-H., et al. (2021) · Clinical Microbiology and Infection

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 284

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

Arbyn, M., Snijders, P. J. F., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Kocjan, B. J., & Poljak, M. (2015) · Clinical Microbiology and Infection

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 275

Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials

Verdoodt, F., Jentschke, M., Hillemanns, P., Racey, C. S., Snijders, P. J. F., & Arbyn, M. (2015) · European Journal of Cancer

Women's cancer prevention and managementCervical Cancer and HPV Research

Cited by 275

High‐risk HPV testing on self‐sampled versus clinician‐collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening

Snijders, P. J. F., Verhoef, V. M. J., Arbyn, M., Ogilvie, G., Minozzi, S., Banzi, R., van Kemenade, F. J., Heideman, D. A. M., & Meijer, C. J. L. M. (2013) · International Journal of Cancer

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 265

Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis

Kyrgiou, M., Mitra, A., Arbyn, M., Stasinou, S. M., Martin-Hirsch, P., Bennett, P., & Paraskevaidis, E. (2014) · BMJ

Cervical Cancer and HPV ResearchReproductive Health and Contraception

Cited by 188

VALGENT: a protocol for clinical validation of human papillomavirus assays

Arbyn, M., Depuydt, C., Benoy, I., Bogers, J., Cuschieri, K., Schmitt, M., Pawlita, M., Geraets, D., Heard, I., Gheit, T., et al. (2016) · Journal of Clinical Virology

Cervical Cancer and HPV ResearchClinical Laboratory Practices and Quality Control

Cited by 157

Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening

Costa, S., Verberckmoes, B., Castle, P. E., & Arbyn, M. (2023) · British Journal of Cancer

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 139

Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

Simms, K. T., Keane, A., Nguyen, D. T. N., Caruana, M., Hall, M. T., Lui, G., Gauvreau, C., Demke, O., Arbyn, M., Basu, P., et al. (2023) · Nature Medicine

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 105

Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis

Athanasiou, A., Veroniki, A. A., Efthimiou, O., Kalliala, I., Naci, H., Bowden, S., Paraskevaidi, M., Arbyn, M., Lyons, D., Martin-Hirsch, P., et al. (2022) · The Lancet Oncology

Cervical Cancer and HPV ResearchEndometrial and Cervical Cancer Treatments

Cited by 85

Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests)

Cuschieri, K., Geraets, D., Cuzick, J., Cadman, L., Moore, C., Vanden Broeck, D., Padalko, E., Quint, W., & Arbyn, M. (2016) · Journal of Clinical Microbiology

Cervical Cancer and HPV ResearchReproductive tract infections research

Cited by 55

Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework

Xu, L., Oštrbenk, A., Poljak, M., & Arbyn, M. (2018) · Journal of Clinical Virology

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 45

The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium.

Bonde, J., Ejegod, D. M., Cuschieri, K., Dillner, J., Heideman, D. A. M., Quint, W., Pavon Ribas, M. A., Padalko, E., Christiansen, I. K., Xu, L., et al. (2018) · Journal of Clinical Virology

Cervical Cancer and HPV ResearchReproductive tract infections research

Cited by 44

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework

Bonde, J. H., Pedersen, H., Quint, W., Xu, L., Arbyn, M., & Ejegod, D. M. (2020) · Journal of Clinical Microbiology

Cervical Cancer and HPV ResearchClinical Laboratory Practices and Quality Control

Cited by 37

Long term outcomes for women treated for cervical precancer

Arbyn, M., Kyrgiou, M., Gondry, J., Petry, K. U., & Paraskevaidis, E. (2014) · BMJ

Cervical Cancer and HPV ResearchEndometrial and Cervical Cancer Treatments

Cited by 35

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework

Oštrbenk, A., Xu, L., Arbyn, M., & Poljak, M. (2018) · Journal of Clinical Microbiology

Cervical Cancer and HPV ResearchReproductive tract infections research

Cited by 34

Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples

Latsuzbaia, A., Tapp, J., Nguyen, T., Fischer, M., Arbyn, M., Weyers, S., & Mossong, J. (2016) · Diagnostic Microbiology and Infectious Disease

Cervical Cancer and HPV ResearchReproductive tract infections research

Cited by 27